Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Darbepoetin alfa may cause the body to make more red blood cells. Red blood cells
contain iron that is needed to carry oxygen to the tissues. It is not yet known whether
giving darbepoetin alfa (DA) together with intravenous iron or oral iron is more effective
than giving darbepoetin alfa together with a placebo in treating anemia caused by
chemotherapy.
PURPOSE: This randomized phase III trial is studying giving darbepoetin alfa together with
iron to see how well it works compared with giving darbepoetin alfa together with a placebo
in treating anemia caused by chemotherapy in patients with cancer.